FDA hands Scholar Rock a CRL for spinal muscular atrophy drugnews2025-09-23T11:25:22+00:00September 23rd, 2025|Endpoints News|
Eli Lilly sells New Jersey site to Celltrion for $330Mnews2025-09-23T10:59:40+00:00September 23rd, 2025|Endpoints News|
FDA rejects Rexulti-Zoloft combo for PTSDnews2025-09-22T19:07:14+00:00September 22nd, 2025|Endpoints News|
Post-Hoc: Pharma threatens the UK to send a message to Europenews2025-09-22T16:24:01+00:00September 22nd, 2025|Endpoints News|
Bristol Myers to launch schizophrenia drug in the UK at the same price as in the USnews2025-09-22T15:11:00+00:00September 22nd, 2025|Endpoints News|
FDA approves Stealth’s rare disease drug after past rejection, delaynews2025-09-22T15:05:16+00:00September 22nd, 2025|Endpoints News|
MBX Biosciences shares Phase 2 hypoparathyroidism data as it seeks to compete with Ascendis, AstraZenecanews2025-09-22T11:00:01+00:00September 22nd, 2025|Endpoints News|
Pfizer goes full speed ahead on obesity with $4.9B acquisition of Metseranews2025-09-22T10:49:36+00:00September 22nd, 2025|Endpoints News|
ACIP recommends that people consult a provider before getting Covid shotsnews2025-09-19T19:54:08+00:00September 19th, 2025|Endpoints News|
Merck wins approval of subcutaneous Keytruda, in bid to extend life of world’s top-selling drugnews2025-09-19T18:24:36+00:00September 19th, 2025|Endpoints News|
